Jun 22, 2018 8:30 am EDT EyeGate Addresses Final FDA Action Item with Submission of IDE Amendment for Ocular Bandage Gel
May 30, 2018 8:30 am EDT EyeGate Files Supplement to Investigational Device Exemption to Commence Study in Punctate Epitheliopathy using the EyeGate Ocular Bandage Gel
May 22, 2018 8:30 am EDT EyeGate Addresses Majority of FDA’s Action Items with Submission of Investigational Device Exemption Amendment for Ocular Bandage Gel
May 11, 2018 8:30 am EDT EyeGate Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
Apr 9, 2018 8:30 am EDT EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
Apr 6, 2018 8:30 am EDT EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis